Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK
(2021)
Journal Article
Youssef, E., Kirkdale, C. L., Wright, D. J., Guchelaar, H. J., & Thornley, T. (2021). Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK. British Journal of Clinical Pharmacology, 87(7), 2907-2925. https://doi.org/10.1111/bcp.14704
Aims: Pharmacogenetics (PGx) in the UK is currently implemented in secondary care for a small group of high-risk medicines. However, most prescribing takes place in primary care, with a large group of medicines influenced by commonly occurring geneti... Read More about Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK.